Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 1 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 3Thoracic 3CNS 3Gastrointestinal 2Breast 2Sarcoma 1Gynecologic 1Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Small Cell Lung Carcinoma 1

Interventions

Carboplatin 347pembrolizumab 322Pemetrexed 246Cisplatin 218Paclitaxel 147Nivolumab 138durvalumab 133osimertinib 112Docetaxel 111atezolizumab 109Specimen Handling 91Radiotherapy 87Drug Therapy 85Magnetic Resonance Spectroscopy 77Etoposide 76Radiosurgery 72Gemcitabine 71Ipilimumab 55130-nm albumin-bound paclitaxel 54Bevacizumab 52cemiplimab 47tislelizumab 44Blood Specimen Collection 40Cetuximab 35Taxes 34Platinum 33Injections 33Biopsy 33Standard of Care 31Immunoglobulin G 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Vaccines × Thoracic × 1 year × Clear all
NCT04487756 2026-06-02

VENEZO-LUNG

Instituto Oncológico Dr Rosell

Phase 1/2 Completed
20 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT07561723 2026-05-12

IMP3-saRNA Vaccine in Advanced NSCLC

West China Hospital

Phase 1 Recruiting
9 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01720836 2025-10-21

Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

University of Pittsburgh

Phase 1/2 Recruiting
30 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡